Peer-reviewed veterinary case report
Cat with FIV and skin allergies died from toxoplasmosis
By Moore, Alexandra et al.·Published in Veterinary dermatology·2022·Animal Dermatology Clinic Perth, Australia·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Fatal disseminated toxoplasmosis in a feline immunodeficiency virus-positive cat receiving oclacitinib for feline atopic skin syndrome.
- Species:
- cat
Plain-English summary
A 6-year-old domestic short hair cat with feline immunodeficiency virus (FIV) and skin allergies was being treated with oclacitinib for five months when it developed severe toxoplasmosis, a serious infection caused by a common parasite. Unfortunately, the cat's weakened immune system made it more vulnerable to this infection, leading to a fatal outcome. This case highlights the risks of treating immunocompromised cats and the importance of monitoring for potential complications.
People also search for: cat FIV treatment · toxoplasmosis in cats symptoms · oclacitinib side effects in cats
Abstract
Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6-year-old, feline immunodeficiency virus-positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35644925/